IMPORTANT UPDATES

Alan Bidgoli, DO

Gender
Male
Language
English

Primary Specialty

Hematology/Oncology


Other Specialty

Pediatric Hematology/Oncology


Education

Board Certification
Am Bd Pediatrics (Sub: Pediatric Hematology-Oncology), American Board of Pediatrics
Medical School:
Philadelphia College of Osteopathic Medicine
Residency:
HCA Healthcare/Mercer University
Fellowship:
Memorial Sloan Kettering Cancer Center
Medical University of South Carolina

Publications

Pubmed Profile

Network


Introduction

Alan Bidgoli, DO, is a Pediatric Hematologist/Oncologist at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta and serves as Assistant Professor at Emory University School of Medicine. An Atlanta native, Dr. Bidgoli completed his undergraduate studies at Georgia Institute of Technology earning a degree in Industrial and Systems Engineering. Following a career in project management, Dr. Bidgoli returned to school and obtained his medical degree at Philadelphia College of Osteopathic Medicine. He then completed his residency training at Memorial Health University in Savannah, Ga. Following his residency, Dr. Bidgoli completed a fellowship at Medical University of South Carolina and a bone marrow transplant/cellular therapy fellowship at Memorial Sloan Kettering Cancer Center.

Focus of Practice

  • Bone marrow transplant
  • Cellular therapy
  • Leukemia and lymphoma

Areas of Interest

  • Post-transplant Immune reconstitution
  • Graft-versus-host disease
  • Plasma and cellular biomarkers

Locations

Aflac Cancer and Blood Disorders Center

Egleston Hospital, 1405 Clifton Road NE Atlanta, GA 30322 Get Directions 404-785-3240

Professional Affiliations

  • Children's Oncology Group
  • American Society of Hematology
  • American Society of Pediatric Hematology/Oncology
  • American Society of Transplantation and Cellular Therapy
  • International Society for Cell and Gene Therapy (ISCT)

Research & Publications

Dr. Bidgoli’s research interests include the impact of CD4+ immune reconstitution on transplant outcomes and acute GVHD.